Bg pattern

MYCOSTATIN 100,000 IU/ml ORAL SUSPENSION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use MYCOSTATIN 100,000 IU/ml ORAL SUSPENSION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

MYCOSTATIN 100,000 IU/ml Oral Suspension

Nystatin

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the Package Leaflet:

  1. What MYCOSTATIN 100,000 IU/ml Oral Suspension is and what it is used for
  2. What you need to know before you take MYCOSTATIN 100,000 IU/ml Oral Suspension
  3. How to take MYCOSTATIN 100,000 IU/ml Oral Suspension
  4. Possible side effects
  5. Storage of MYCOSTATIN 100,000 IU/ml Oral Suspension
  6. Contents of the pack and other information

1. What MYCOSTATIN 100,000 IU/ml Oral Suspension is and what it is used for

MYCOSTATIN is an antifungal medicine used to treat oral and intestinal infections caused by a fungus called Candida.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you take MYCOSTATIN 100,000 IU/ml Oral Suspension

Do not take MYCOSTATIN

  • if you are allergic to nystatin or any of the other ingredients of this medicine (listed in section 6).
  • for the treatment of generalized infections of the body.

Warnings and Precautions

Consult your doctor or pharmacist before taking MYCOSTATIN.

In case of irritation or sensitization, consult your doctor immediately.

If you do not get a therapeutic response after 14 days of taking this medicine, consult your doctor.

Even if relief of symptoms occurs in the first few days of treatment, do not stop taking this medicine until the end of the treatment period indicated by your doctor.

Taking MYCOSTATIN with other medicines

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.

After taking MYCOSTATIN, do not take substances that modify intestinal movement or that can isolate the intestinal mucosa from nystatin, as the action of nystatin may be diminished.

Taking MYCOSTATIN with food and drinks

No interactions with food or drinks have been described; however, you should avoid taking substances that can affect intestinal movement or isolate the intestinal mucosa, and thus diminish the action of nystatin, after taking this medicine.

Pregnancy and Breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor for advice before taking this medicine.

Driving and Using Machines

MYCOSTATIN does not affect the ability to drive and use machines.

MYCOSTATIN containssucrose, ethanol, methylparaben (E-218), propylparaben (E-216), and sodium

This medicine contains 500 mg of sucrose per ml, which should be taken into account in patients with diabetes mellitus. If your doctor has told you that you have an intolerance to some sugars, consult with them before taking this medicine.

This medicine contains 455 mg of alcohol (ethanol) in each 60 ml, which corresponds to an amount of 0.76 g in each 100 ml. The amount in 1 ml of this medicine is equivalent to less than 0.2 ml of beer or 0.1 ml of wine.

The small amount of alcohol in this medicine does not produce any noticeable effect.

It may cause allergic reactions (possibly delayed), as it contains methylparaben (E-218) and propylparaben (E-216).

This medicine contains less than 1 mmol of sodium (23 mg) per ml, which is essentially "sodium-free".

3. How to take MYCOSTATIN 100,000 IU/ml Oral Suspension

Follow exactly the administration instructions of this medicine indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.

Your doctor will indicate the duration of your treatment with MYCOSTATIN. The treatment should continue for at least 48 hours after the disappearance of symptoms.

If the signs and symptoms worsen or persist after 14 days of treatment, the patient should be reevaluated and an alternative treatment should be considered.

The recommended dose is:

Adults:

  • Oral candidiasis: 2.5 - 5 ml (250,000 - 500,000 IU) every 6-12 hours.
  • Intestinal candidiasis: 5 - 10 ml (500,000 - 1,000,000 IU) every 6 hours.

Pediatric population:

  • Oral candidiasis
    • Infants over 1 year, children, and adolescents: 2.5 - 5 ml (250,000 - 500,000 IU) every 6-12 hours.
    • Infants under or equal to 1 year: 2.5 ml (250,000 IU) every 6 hours.
    • Newborns and infants with low birth weight: 1 ml (100,000 IU) every 6 hours.
  • Intestinal candidiasis:
    • Children and adolescents: 2.5 - 7.5 ml (250,000 - 750,000 IU) every 6 hours.
    • Infants: 1 - 3 ml (100,000 - 300,000 IU) every 6 hours.

Method of administration:

A dosing syringe is included in the package for oral administration.

First use:

  1. Remove the adapter from the syringe (see image 1)
  2. Remove the cap from the vial
  3. Insert the adapter into the vial (see image 2)
  4. Cover the vial.

Each time you use it:

  • Preparing the delivery device
  1. Shake the suspension before each use
  2. Remove the cap from the vial
  3. Place the syringe in the adapter (see image 3)
  4. Turn the vial/syringe assembly upside down (see image 4)
  5. Fill the syringe with a small amount of medicine by pulling the plunger and then pushing the plunger up to avoid the formation of air bubbles.
  • Preparing the dose
  1. Make sure the plunger is at the bottom of the syringe (see image 5)
  2. Slowly pull the plunger to extract the required dose with the dosing syringe
  3. Once the dose is extracted, turn the vial/syringe assembly upside down and remove it by gently twisting the syringe containing the dose to be administered
  4. Insert the tip of the syringe directly into the mouth
  5. Administer the entire extracted volume immediately by slowly pressing the plunger.

After each use:

  1. Close the vial with the cap, leaving the adapter in the vial
  2. Rinse the syringe with water, repeating the action
  3. Store the syringe dry in the package.

Never separate the dosing syringe from the other components of the medicine package (box, leaflet).

Transparent syringe with vertical numerical scale and black upper plunger pressed downMedicine bottle with rubber cap and removable protector, arrows indicate direction of cap removalHand holding a syringe with a connected needle pointing towards a vial with a rubber cap and arrow indicating direction

Image 1 Image 2 Image 3

Syringe with numerical scale and transparent plunger, curved black arrow indicates rotation to adjust the doseHand holding a device with a black arrow pointing up and a horizontal upper line

Image 4 Image 5

The suspension can be administered alone, with the help of water, or mixed with a liquid or soft food that is not acidic, such as milk, honey, jelly, etc.

In case of oral candidiasis, keep the suspension in the mouth for as long as possible (several minutes) before swallowing. For infants or small children, apply half the dose to each side of the mouth.

If you take more MYCOSTATIN than you should

Given the low absorption of this medicine, the possibility of intoxication, even by accidental ingestion, is very unlikely.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount ingested.

If you forget to take MYCOSTATIN

If you forget to take a dose, and if it is not close to the next dose, wait to take the next dose. Do not take a double dose to make up for forgotten doses.

If you stop taking MYCOSTATIN

Do not stop treatment before your doctor indicates, as resistance to the medicine may occur, making it difficult to treat subsequent reinfections.

If you have any other questions about the use of this medicine, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible Side Effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

The following side effects have been observed:

Uncommon (may affect up to 1 in 100 people): nausea, vomiting, gastrointestinal discomfort, and diarrhea, especially with high doses.

In some cases, the appearance of rash (skin eruption), including urticaria, has been reported. Very occasionally, Stevens-Johnson syndrome (characterized by skin, mucous membrane, and eye disorders) has been manifested. Cases of hypersensitivity (allergy) and angioedema (inflammation of the deeper layers of the skin), including facial edema (fluid accumulation in the face), have also been reported.

Reporting of Side Effects

If you experience any side effects, talk to your doctor or pharmacist, even if it is possible side effects not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of MYCOSTATIN 100,000 IU/ml Oral Suspension

Keep this medicine out of the sight and reach of children.

Before opening the bottle for the first time, store below 30°C.

After opening the bottle, store below 25°C; in these conditions, the expiration period is 7 days.

Do not use this medicine after the expiration date stated on the package after EXP. The expiration date is the last day of the month indicated.

Do not use this medicine if you notice any visible signs of deterioration (e.g., change in appearance of the suspension or its color, odor, or taste).

Medicines should not be disposed of via wastewater or household waste. Place the package and any unused medicine in the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the package and any unused medicine. This will help protect the environment.

6. Contents of the Pack and Other Information

Composition of MYCOSTATIN

  • The active substance is nystatin. Each ml of oral suspension contains 100,000 IU of nystatin.
  • The other ingredients are sucrose, ethanol 96%, sodium carmellose (E-466), cinnamaldehyde, peppermint flavor, cherry flavor, anhydrous disodium phosphate, glycerol (E-422), methylparaben (E-218), propylparaben (E-216), sodium hydroxide, hydrochloric acid, and purified water.

Appearance of the Product and Contents of the Pack

MYCOSTATIN is presented as a yellowish, opaque, and homogeneous oral suspension with a cherry and mint flavor.

Each package contains a bottle with 30 or 60 ml of suspension, accompanied by a graduated dosing syringe from 0.5 to 5 ml (for oral use) and an adapter to fix it to the bottle.

Marketing Authorization Holder and Manufacturer

Marketing Authorization Holder:

SUBSTIPHARM

24 rue Erlanger

75016 Paris

France

Manufacturer:

Vetprom AD

The Vpharma site,

Otets Paisiy Str.

Radomir, 2400,

Bulgaria

Date of the Last Revision of this Leaflet: June 2025.

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.

Online doctors for MYCOSTATIN 100,000 IU/ml ORAL SUSPENSION

Discuss questions about MYCOSTATIN 100,000 IU/ml ORAL SUSPENSION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for MYCOSTATIN 100,000 IU/ml ORAL SUSPENSION?
MYCOSTATIN 100,000 IU/ml ORAL SUSPENSION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in MYCOSTATIN 100,000 IU/ml ORAL SUSPENSION?
The active ingredient in MYCOSTATIN 100,000 IU/ml ORAL SUSPENSION is nystatin. This information helps identify medicines with the same composition but different brand names.
How much does MYCOSTATIN 100,000 IU/ml ORAL SUSPENSION cost in pharmacies?
The average pharmacy price for MYCOSTATIN 100,000 IU/ml ORAL SUSPENSION is around 4.68 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures MYCOSTATIN 100,000 IU/ml ORAL SUSPENSION?
MYCOSTATIN 100,000 IU/ml ORAL SUSPENSION is manufactured by Substipharm. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of MYCOSTATIN 100,000 IU/ml ORAL SUSPENSION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether MYCOSTATIN 100,000 IU/ml ORAL SUSPENSION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to MYCOSTATIN 100,000 IU/ml ORAL SUSPENSION?
Other medicines with the same active substance (nystatin) include DIFICLIR 200 mg FILM-COATED TABLETS, DIFICLIR 40 mg/ml ORAL SUSPENSION GRANULES, HUMATIN 250 mg HARD CAPSULES. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media